Thank you, Mr. Chair.
Thank you, all, for coming.
Dr. Downes, I was reading your testimony. You stated that there are a number of military members and veterans who are concerned that they have long-term psychiatric symptoms, and they are concerned whether mefloquine could have contributed to their illness. You then go on to say the concern is understandable given the level of discussion and debate in the media and in the scientific and medical communities.
One of the things we deal with in medicine, and in research as well as medicine, is confirmation bias. Do you think there's any role of confirmation bias in some of the claims being made by certain investigators and certain advocates of this point of view as to whether certain individuals may or may not have so-called toxicity to mefloquine?